Where does Clearmind Medicine Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Clearmind Medicine Inc. ranks #45,723 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Clearmind Medicine Inc. hold?

Clearmind Medicine Inc. holds 5 US utility patents granted between 2021 and 2025, spanning 5 technology areas.

What is Clearmind Medicine Inc.'s Innovation Score?

Clearmind Medicine Inc. has an Innovation Score of 36.5 out of 100 (top 46% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Clearmind Medicine Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Clearmind Medicine Inc..

What does claim depth mean for Clearmind Medicine Inc.'s patents?

Clearmind Medicine Inc.'s patents average 15.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Clearmind Medicine Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Clearmind Medicine Inc.

Q: What technology areas does Clearmind Medicine Inc. focus on?

Clearmind Medicine Inc.'s top technology area is A23L (Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof) with 5 patents, ranking #336 of 1,325 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

USPTO PatentsView assignee record - 5 granted patents across 5 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A23L (Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Clearmind ranks #45,723 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 5 technology areas.

#45,723
of 49,997 US assignees by volume: Top 46%
by Innovation Score (36.5/100): 15.2
avg claims per patent

USPTO PatentsView assignee plate

Corpus R45723 · Foreign Corporation #45,723 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 5 grants
BOTTOM-DECILE #45,723/49,997
PHOTO-FINISH Cleansorb
CPC-NARROW A23L · 5 areas
INNOV-THIN 36.5/100
CLAIMS-RICH 15.2 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2021–2025 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Cleansorb Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Clearmind’s 36.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (17%) Velocity 13.3 pts (36%) Breadth 7.9 pts (22%) Claim depth 9.1 pts (25%)

Qualcomm Incorporated · highest

85
Clearmind Medicine · this assignee

37
3D Lighting… · lowest

7

What this shows Clearmind's Innovation Score is 36.5/100 (top 46% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Clearmind?

Each dot is one of Clearmind’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Clearmind’s own 15.2 claims/patent is ABOVE the 10.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Clearmind vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Clearmind's grants concentrate

Clearmind Medicine Inc. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under A23L (Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof). By volume, Clearmind sits between Cleansorb Limited and Clinton Electronics Corporation.

Clearmind's three-year grant acceleration

Clearmind Medicine Inc. shows 2 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Cleansorb

5
Clear Innovation

5
Clearist

5
Clearmind Biomedi…

5
Clever Culture Sy…

5
Clics

5
Climate Recovery…

5
Clinton

5
Clearmind Medicine ◀

5

What this shows Clearmind holds 5 patents at rank #45,575, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Clearmind

By rank, the assignees closest to #45,575 in granted patent volume.

Leaders in A23L (Foods)

Other assignees with the most granted patents in Clearmind's primary technology class.

Clearmind's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 46% higher than 54% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Clearmind Medicine Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	1	20.0%
2022	1	20.0%
2024	1	20.0%
2025partial year	2	40.0%

Which technologies does Clearmind Medicine Inc. patent most?

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 5

C12G - WINE; Preparation THEREOF; Alcoholic Beverages ; Preparation OF Alcoholic Beverages NOT Provided FOR IN Subclasses C12c OR C12h 5

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 5

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 5

C12C - BEER; Preparation OF Beer BY Fermentation ; Preparation OF Malt FOR Making BEER; Preparation OF Hops FOR Making Beer 4

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Clearmind Medicine Inc.'s patent record in context - here's where to go next.

Clearmind Medicine Inc.'s lead technology class is A23L (Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof), 100% of its portfolio - see every assignee active in that class. Explore A23L
Ranked #45,723 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Clearmind Medicine Inc. against Cleansorb Limited, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 36.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.